Evidence map›Paper›PMID 29846545›Full record

ArticleDatabase : the journal of biological databases and curation2018

CBD: a biomarker database for colorectal cancer.

Xueli Zhang, Xiao-Feng Sun, Yang Cao, Benchen Ye, Qiliang Peng, Xingyun Liu, Bairong Shen, Hong Zhang

Open access · goldAbstract read
In one paragraph

Article in Database : the journal of biological databases and curation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. EBD: an eye biomarker database.Bioinformatics (Oxford, England) · 2023
    Article
  10. Article
  11. Review
  12. LiqBioer: a manually curated database of cancer biomarkers in body fluid.Database : the journal of biological databases and curation · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xueli ZhangSchool of Medicine, Institute of Medical Sciences, Örebro University, SE 70182 Örebro, Sweden.
Xiao-Feng SunDepartment of Oncology and Department of Clinical and Experimental Medicine, Linköping University, SE 58183 Linköping, Sweden.
Yang CaoClinical Epidemiology and Biostatistics, Institute of Medical Sciences, Örebro University, SE 70182 Örebro, Sweden.
Benchen YeCentre for Systems Biology, Soochow University, Suzhou 215006, China.
Qiliang PengDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Xingyun LiuCentre for Systems Biology, Soochow University, Suzhou 215006, China.
Bairong ShenCentre for Systems Biology, Soochow University, Suzhou 215006, China.
Hong ZhangSchool of Medicine, Institute of Medical Sciences, Örebro University, SE 70182 Örebro, Sweden.
Soochow University · CNÖrebro University · SELinköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) biomarker database (CBD) was established based on 870 identified CRC biomarkers and their relevant information from 1115 original articles in PubMed published from 1986 to 2017. In this version of the CBD, CRC biomarker data were collected, sorted, displayed and analysed. The CBD with the credible contents as a powerful and time-saving tool provide more comprehensive and accurate information for further CRC biomarker research. The CBD was constructed under MySQL server. HTML, PHP and JavaScript languages have been used to implement the web interface. The Apache was selected as HTTP server. All of these web operations were implemented under the Windows system. The CBD could provide to users the multiple individual biomarker information and categorized into the biological category, source and application of biomarkers; the experiment methods, results, authors and publication resources; the research region, the average age of cohort, gender, race, the number of tumours, tumour location and stage. We only collect data from the articles with clear and credible results to prove the biomarkers are useful in the diagnosis, treatment or prognosis of CRC. The CBD can also provide a professional platform to researchers who are interested in CRC research to communicate, exchange their research ideas and further design high-quality research in CRC. They can submit their new findings to our database via the submission page and communicate with us in the CBD.Database URL: http://sysbio.suda.edu.cn/CBD/.

Indexed as

Biomarkers, TumorColorectal NeoplasmsDatabases, BibliographicDatabases, GeneticProgramming LanguagesData MiningHumansBiomarkers, Tumor

Identifiers

PMID29846545
PMCPMC6007224
OpenAlexW2809618715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.